MD

Minal Deole Uttam

Active Director Additional Director DIN 08105403
DIN 08105403 First appointment Apr 2018 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2018
Shareholding value •••• Premium profile

About Minal Deole Uttam

Data last updated:

Minal Deole Uttam is an Additional Director at Genics Pharmaceutical Private Limited (since 2018). The company operates in Pharma. Genics Pharmaceutical Private Limited reported revenue of ₹61.1 Lakh (FY 2024).

DIN 08105403
Primary Designation Additional Director
Industry Pharma
First Appointment 04 Apr 2018
Oldest Company Age 11 yrs
Largest company Genics Pharmaceutical Private Limited · ₹61.1 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Additional Director04 Apr 20182015₹61.1 Lakh (FY 2024)Active

Board colleagues of Minal Deole Uttam

Directorship timeline

Open interactive timeline →
Genics Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Minal Deole Uttam

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Minal Deole Uttam

Minal Deole Uttam currently holds 1 directorship: Genics Pharmaceutical Private Limited (Additional Director, since 04 Apr 2018, revenue ₹61.1 Lakh (FY 2024)).

Minal Deole Uttam was first appointed on 04 Apr 2018 as Additional Director at Genics Pharmaceutical Private Limited.

The current boards of Minal Deole Uttam's companies include Uttamrao Deole Shankarrao (Genics Pharmaceutical Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available